The Association Between HbA1c and 1-Year Diabetes-Related Medical Costs: A Retrospective Claims Database Analysis.

Kristina S BoyeMaureen J LageVivian T Thieu

Published in: Diabetes therapy : research, treatment and education of diabetes and related disorders (2022)

Glycemic control was found to be associated with significantly lower annual diabetes-related component and total costs. Results suggest economic benefits associated with having HbA1c at or below target.

Keyphrases

glycemic control
type diabetes
blood glucose
cardiovascular disease
weight loss
insulin resistance
healthcare
emergency department
adipose tissue